2019
DOI: 10.1007/s00417-019-04303-4
|View full text |Cite
|
Sign up to set email alerts
|

Usefulness of the dacryoscintigraphy in patients with nasolacrimal duct obstruction prior to endoscopic dacryocystorhinostomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 23 publications
0
6
0
Order By: Relevance
“…Classifying patients with primary NLDO by DSG does not appear to predict anatomic or functional success rates, although DSG is recognized as a sensitive test for initial assessment of anatomic obstruction 15,16 . In contrast, classifying functional cases using DSG has been shown to accurately predict outcomes.…”
Section: Discussionmentioning
confidence: 97%
See 3 more Smart Citations
“…Classifying patients with primary NLDO by DSG does not appear to predict anatomic or functional success rates, although DSG is recognized as a sensitive test for initial assessment of anatomic obstruction 15,16 . In contrast, classifying functional cases using DSG has been shown to accurately predict outcomes.…”
Section: Discussionmentioning
confidence: 97%
“…14 Classifying patients with primary NLDO by DSG does not appear to predict anatomic or functional success rates, although DSG is recognized as a sensitive test for initial assessment of anatomic obstruction. 15,16 In contrast, classifying functional cases using DSG has been shown to accurately predict outcomes. Distal duct obstructions have been found to respond very favorably to silicone tube intubations, while patients with proximal duct and prelacrimal sac involvement may warrant alternative treatments or further adjunctive therapies.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Gamma scintigraphy was first assessed by Rossomondo et al in 1972 [56], and was later used with modifications in preclinical studies [57] and in humans [58,59,60,61,62] to assess the lacrimal drainage and the lacrimal gland inflammation [63]. Subsequently, it has been used with the aim of understanding the ocular surface biodistribution of different formulations used as drug delivery vehicles in mice and humans, as it is the case for artificial lacrimal products that contain hydroxypropyl methylcellulose (HPMC), a combination of PVA and gellan gum for antiglaucoma drug release [64,65], PVA [66,67,68] or sodium hyaluronate [69].…”
Section: Spectmentioning
confidence: 99%